164 related articles for article (PubMed ID: 21673552)
1. Serious adverse reactions should be further monitored after influenza A (H1N1) vaccination among children: postmarketing experience with 570,000 vaccinations between October 2009 and August 2010 in Guangzhou, China.
Fu C; Xu J; Tan H; Wang M
Pediatr Infect Dis J; 2011 Jul; 30(7):631-2. PubMed ID: 21673552
[No Abstract] [Full Text] [Related]
2. Adverse events following immunization (AEFI) with the novel influenza a (H1N1) 2009 vaccine: findings from the national registry of all vaccine recipients and AEFI and the passive surveillance system in South Korea.
Kim JH; Cho HY; Hennessey KA; Lee HJ; Bae GR; Kim HC
Jpn J Infect Dis; 2012; 65(2):99-104. PubMed ID: 22446114
[TBL] [Abstract][Full Text] [Related]
3. Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China.
Liang XF; Li L; Liu DW; Li KL; Wu WD; Zhu BP; Wang HQ; Luo HM; Cao LS; Zheng JS; Yin DP; Cao L; Wu BB; Bao HH; Xu DS; Yang WZ; Wang Y
N Engl J Med; 2011 Feb; 364(7):638-47. PubMed ID: 21288090
[TBL] [Abstract][Full Text] [Related]
4. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010.
Vellozzi C; Broder KR; Haber P; Guh A; Nguyen M; Cano M; Lewis P; McNeil MM; Bryant M; Singleton J; Martin D; DeStefano F
Vaccine; 2010 Oct; 28(45):7248-55. PubMed ID: 20850534
[TBL] [Abstract][Full Text] [Related]
5. The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: a capture-recapture analysis.
Huang WT; Huang WI; Huang YW; Hsu CW; Chuang JH
Vaccine; 2012 Mar; 30(12):2168-72. PubMed ID: 22265861
[TBL] [Abstract][Full Text] [Related]
6. Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: reports to VAERS.
Halsey NA; Griffioen M; Dreskin SC; Dekker CL; Wood R; Sharma D; Jones JF; LaRussa PS; Garner J; Berger M; Proveaux T; Vellozzi C; ; Broder K; Setse R; Pahud B; Hrncir D; Choi H; Sparks R; Williams SE; Engler RJ; Gidudu J; Baxter R; Klein N; Edwards K; Cano M; Kelso JM
Vaccine; 2013 Dec; 31(51):6107-12. PubMed ID: 24120547
[TBL] [Abstract][Full Text] [Related]
7. Two doses of pandemic influenza A(H1N1) vaccine: tolerability in healthy young children in the Netherlands.
van't Klooster TM; Kemmeren JM; de Melker HE; Vermeer-de Bondt PE; van der Maas NA
Hum Vaccin; 2011 Oct; 7(10):1048-54. PubMed ID: 21957494
[TBL] [Abstract][Full Text] [Related]
8. Adverse events associated with the 2009 H1N1 influenza vaccination and the vaccination coverage rate in health care workers.
Park SW; Lee JH; Kim ES; Kwak YG; Moon CS; Yeom JS; Lee JH; Lee CS
Am J Infect Control; 2011 Feb; 39(1):69-71. PubMed ID: 21122948
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of adverse events following 2009 influenza A (H1N1) vaccinoprophylaxis in Beijing].
Miao L; Lu L; Wu J; Suo LD; Liu DL; Sun MP; Pang XH; Deng Y; Wang XL
Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Oct; 44(10):884-7. PubMed ID: 21176517
[TBL] [Abstract][Full Text] [Related]
10. Acute encephalomyelitis syndromes associated with H1N1 09 influenza vaccination.
Denholm JT; Neal A; Yan B; Petty S; Knox J; French C; Marshall C
Neurology; 2010 Dec; 75(24):2246-8. PubMed ID: 21172848
[No Abstract] [Full Text] [Related]
11. The safety of the H1N1 influenza A vaccine in egg allergic individuals.
Greenhawt MJ; Chernin AS; Howe L; Li JT; Sanders G
Ann Allergy Asthma Immunol; 2010 Nov; 105(5):387-93. PubMed ID: 21055666
[TBL] [Abstract][Full Text] [Related]
12. Acceptance and adverse events of the 2009 H1N1 vaccination in immunosuppressed pediatric liver transplant recipients.
Goldschmidt I; Pfister ED; Becker M; Häckl S; Bott OJ; Baumann U; Baumann U
J Pediatr; 2011 Feb; 158(2):329-33. PubMed ID: 21163496
[TBL] [Abstract][Full Text] [Related]
13. [Pandemic vaccines].
Floret D
Arch Pediatr; 2010 Jun; 17(6):906-7. PubMed ID: 20654954
[No Abstract] [Full Text] [Related]
14. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
[TBL] [Abstract][Full Text] [Related]
15. 2009-2010 novel influenza A (H1N1) vaccination coverage in the Republic of Korea.
Lee YK; Kwon Y; Kim DW; Song KM; Cho H; Kim CH; Go UY; Bae GR; Lee JK
Am J Infect Control; 2012 Jun; 40(5):481-3. PubMed ID: 21868134
[TBL] [Abstract][Full Text] [Related]
16. Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: results of a national vaccination campaign.
Bone A; Guthmann JP; Nicolau J; Lévy-Bruhl D
Vaccine; 2010 Nov; 28(51):8157-61. PubMed ID: 20937310
[TBL] [Abstract][Full Text] [Related]
17. Italian post-marketing surveillance for adverse event reports after MF59-adjuvanted H1N1v vaccination.
Parretta E; Ianniello B; Ferrazin F; Rossi F; Capuano A
Vaccine; 2011 May; 29(20):3708-13. PubMed ID: 21406267
[TBL] [Abstract][Full Text] [Related]
18. Vaccines against influenza A (H1N1) pandemic.
Valdespino-Gomez JL; Garcia-Garcia L; de León-Rosales SP
Arch Med Res; 2009 Nov; 40(8):693-704. PubMed ID: 20304259
[TBL] [Abstract][Full Text] [Related]
19. Allergic symptoms after pandemic influenza vaccination rarely mediated by vaccine-specific IgE.
Rouleau I; De Serres G; Drolet JP; Banerjee D; Lemire C; Moore A; Paradis L; Alizadhefar R; Des Roches A; Chan ES; Stark D; Benoit M; Skowronski DM;
J Allergy Clin Immunol; 2012 Dec; 130(6):1423-6. PubMed ID: 22958947
[No Abstract] [Full Text] [Related]
20. Administration of influenza vaccines to patients with egg allergy.
Kelso JM
J Allergy Clin Immunol; 2010 Apr; 125(4):800-2. PubMed ID: 20226505
[No Abstract] [Full Text] [Related]
[Next] [New Search]
